4.7 Article Proceedings Paper

Transcriptional-mediated effects of radiation on the expression of immune susceptibility markers in melanoma

期刊

RADIOTHERAPY AND ONCOLOGY
卷 124, 期 3, 页码 418-426

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2017.08.016

关键词

Immunomodulation; Radiation; Melanoma; Immunotherapy

资金

  1. Department of Human Oncology Head and Neck Cancer Research Fund
  2. University of Wisconsin Carbone Cancer Center Core Grant [P30 CA014520]
  3. NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE026787] Funding Source: NIH RePORTER
  5. OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD024576] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Background and purpose: We recently reported a time-sensitive, cooperative, anti-tumor effect elicited by radiation (RT) and intra-tumoral-immunocytokine injection in vivo. We hypothesized that RT triggers transcriptional-mediated changes in tumor expression of immune susceptibility markers at delayed time points, which may explain these previously observed time-dependent effects. Materials and methods: We examined the time course of changes in expression of immune susceptibility markers following in vitro or in vivo RT in B78 murine melanoma and A375 human melanoma using flow cytometry, immunoblotting, and qPCR. Results: Flow cytometry and immunoblot revealed time-dependent increases in expression of death receptors and T cell co-stimulatory/co-inhibitory ligands following RT in murine and human melanoma. Using high-throughput qPCR, we observed comparable time courses of RT-induced transcriptional upregulation for multiple immune susceptibility markers. We confirmed analogous changes in B78 tumors irradiated in vivo. We observed upregulated expression of DNA damage response markers days prior to changes in immune markers, whereas phosphorylation of the STAT1 transcription factor occurred concurrently with changes following RT. Conclusion: This study highlights time-dependent, transcription-mediated changes in tumor immune susceptibility marker expression following RT. These findings may help in the design of strategies to optimize sequencing of RT and immunotherapy in translational and clinical studies. (C) 2017 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

In situ vaccination at a peripheral tumor site augments response against melanoma brain metastases

Paul A. Clark, Raghava N. Sriramaneni, Won Jong Jin, Justin C. Jagodinsky, Amber M. Bates, Abigail A. Jaquish, Bryce R. Anderson, Trang Le, Jonathan A. Lubin, Ishan Chakravarty, Ian S. Arthur, Clinton M. Heinze, Emily Guy, Jasdeep Kler, Kelsey A. Klar, Peter M. Carlson, Kyung Mann Kim, John S. Kuo, Zachary S. Morris

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Article Medicine, General & Internal

Cohort profile: the COVID-19 Coping Study, a longitudinal mixed-methods study of middle-aged and older adults' mental health and well-being during the COVID-19 pandemic in the USA

Lindsay C. Kobayashi, Brendan Q. O'Shea, Jasdeep S. Kler, Raphael Nishimura, Caroline B. Palavicino-Maggio, Marisa R. Eastman, Yamani Rikia Vinson, Jessica M. Finlay

Summary: The COVID-19 Coping Study is a national longitudinal study investigating the impact of pandemic-related stressors on mental health and well-being among middle-aged and older adults. Findings show a significant portion of adults only leaving home for essential purposes, with a proportion of workers being placed on leave or furloughed due to the pandemic. Additionally, a considerable number of individuals screened positive for depression, anxiety, and loneliness.

BMJ OPEN (2021)

Article Oncology

Progesterone promotes immunomodulation and tumor development in the murine mammary gland

Lauryn R. Werner, Katelin A. Gibson, Merit L. Goodman, Dominika E. Helm, Katherine R. Walter, Sean M. Holloran, Gloria M. Trinca, Richard C. Hastings, Howard H. Yang, Ying Hu, Junping Wei, Gangjun Lei, Xiao-Yi Yang, Rashna Madan, Alfredo A. Molinolo, Mary A. Markiewicz, Prabhakar Chalise, Margaret L. Axelrod, Justin M. Balko, Kent W. Hunter, Zachary C. Hartman, Carol A. Lange, Christy R. Hagan

Summary: Clinical studies have linked the use of progestins, synthetic progesterone, to an increased risk of breast cancer. However, the specific role of native progesterone signaling through the progesterone receptor in breast tumor formation remains poorly understood. Research suggests that progesterone can repress certain immune signaling pathways, potentially promoting tumor development in the mammary gland. This study investigated the effects of progesterone on immune cell populations in mouse mammary glands, as well as the impact of progesterone receptor overexpression on tumor formation and immune cell populations. The findings indicate that progesterone treatment and progesterone receptor overexpression are associated with inhibited immune responses, decreased immune cell populations, and an increased risk of mammary gland tumor development in mice.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Oncology

Depth of tumor implantation affects response to in situ vaccination in a syngeneic murine melanoma model

Peter M. Carlson, Manasi Mohan, Matthew Rodriguez, Vladimir Subbotin, Claire X. Sun, Ravi B. Patel, Jen Birstler, Jacquelyn A. Hank, Alexander L. Rakhmilevich, Zachary S. Morris, Amy K. Erbe, Paul M. Sondel

Summary: This study found that differences in depth of tumor implantation can lead to variations in response to immunotherapy. The mobile or fixed characteristics of tumors may predict response to therapy, regardless of intended implantation depth. This suggests that physical examination of tumor characteristics can ensure consistent tumor depth for immunotherapy experiments.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Public, Environmental & Occupational Health

Coping During the COVID-19 Pandemic: A Qualitative Study of Older Adults Across the United States

Jessica M. Finlay, Jasdeep S. Kler, Brendan Q. O'Shea, Marisa R. Eastman, Yamani R. Vinson, Lindsay C. Kobayashi

Summary: This study identifies various coping strategies adopted by older adults during the early stages of the COVID-19 pandemic, including exercise, modifying routines, following public health guidelines, adjusting attitudes, and staying socially connected. While some coping strategies may be detrimental to health (e.g., overeating), the majority encourage personal improvement, positive adjustment, and overall well-being.

FRONTIERS IN PUBLIC HEALTH (2021)

Article Immunology

Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice

Peter M. Carlson, Manasi Mohan, Ravi B. Patel, Jen Birstler, Lauren Nettenstrom, Dagna Sheerar, Kathryn Fox, Matthew Rodriguez, Anna Hoefges, Reinier Hernandez, Chris Zahm, KyungMann Kim, Douglas G. McNeel, Jamey Weichert, Zachary S. Morris, Paul M. Sondel

Summary: Most shared resource flow cytometry facilities do not allow analysis of radioactive samples. Researchers are investigating a low-dose molecular targeted radionuclide therapy as an immunomodulator and need a reliable method for cryopreserving immune samples for flow cytometry analysis. Evaluating different fixation and cryopreservation protocols, it was found that freezing samples after all staining and fixation are completed most accurately matches noncryopreserved results.

JOURNAL OF IMMUNOLOGY (2021)

Article Public, Environmental & Occupational Health

Loneliness Among US Adults Aged ≥55 Early in the COVID-19 Pandemic Findings From the COVID-19 Coping Study

Brendan Q. O'Shea, Jessica M. Finlay, Jasdeep Kler, Carly A. Joseph, Lindsay C. Kobayashi

Summary: The study estimated the prevalence of loneliness among US adults aged >= 55 during the early phase of the COVID-19 pandemic, finding that loneliness was most prevalent among those who reported depression, were not married or in a relationship, lived alone, and were unemployed at the onset of the pandemic.

PUBLIC HEALTH REPORTS (2021)

Article Cell Biology

Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade

Ravi B. Patel, Reinier Hernandez, Peter Carlson, Joseph Grudzinski, Amber M. Bates, Justin C. Jagodinsky, Amy Erbe, Ian R. Marsh, Ian Arthur, Eduardo Aluicio-Sarduy, Raghava N. Sriramaneni, Won Jong Jin, Christopher Massey, Alexander L. Rakhmilevich, David Vail, Johnathan W. Engle, Trang Le, Kyung Mann Kim, Bryan Bednarz, Paul M. Sondel, Jamey Weichert, Zachary S. Morris

Summary: The study demonstrates that delivering radiation semiselectively to tumors through targeted radionuclide therapy (TRT) can enhance response to immune checkpoint inhibitors (ICIs), leading to therapeutic efficacy and tumor-specific T cell memory in murine models. Combination of TRT and ICI activates production of proinflammatory cytokines, promotes tumor infiltration by CD8(+) T cells, and reduces metastases, suggesting a promising approach to improve response to ICIs for various tumor types.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Oncology

Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice

Alexander A. Pieper, Alexander L. Rakhmilevich, Daniel Spiegelman, Ravi B. Patel, Jen Birstler, Won Jong Jin, Peter M. Carlson, Deborah H. Charych, Jacquelyn A. Hank, Amy K. Erbe, Willem W. Overwijk, Zachary S. Morris, Paul M. Sondel

Summary: The combination of local RT and BEMPEG showed a cooperative antitumor effect in multiple immunologically 'cold' tumor models, along with increased IL-2 receptor expression on peripheral T cells. Adding immune checkpoint blockade to RT+BEMPEG further strengthened the antitumor response in some models.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Oncology

Validation of Self-reported Cancer Diagnoses Using Medicare Diagnostic Claims in the US Health and Retirement Study, 2000-2016

Megan A. Mullins, Jasdeep S. Kler, Marisa R. Eastman, Mohammed Kabeto, Lauren P. Wallner, Lindsay C. Kobayashi

Summary: This study found that self-reported cancer diagnoses in the US Health Retirement Study (HRS) have reasonable validity, especially when linked to Medicare claims. These findings have implications for population-based cancer and aging research.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Review Environmental Sciences

A state-of-the-science review and guide for measuring environmental exposure biomarkers in dried blood spots

Tyler A. Jacobson, Jasdeep S. Kler, Yeunook Bae, Jiexi Chen, Daniel T. Ladror, Ramsunder Iyer, Denise A. Nunes, Nathan D. Montgomery, Joachim D. Pleil, William E. Funk

Summary: Dried blood spot (DBS) sampling is a simple, cost-effective, and minimally invasive alternative for measuring exposure biomarkers in public health and epidemiological research. High-performing DBS methods have been developed and applied for detecting environmental exposures, but further research is needed for measuring other substances.

JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Combined Targeted Radiopharmaceutical Therapy and Immune Checkpoint Blockade: From Preclinical Advances to the Clinic

Michael C. Bellavia, Ravi B. Patel, Carolyn J. Anderson

Summary: Immune checkpoint inhibitors (ICIs) have revolutionized cancer care, but many patients with poorly immunogenic tumors fail to benefit. External beam radiotherapy (EBRT) has been shown to synergize with ICI to prompt remarkable tumor regression and even eradication, but is not suitable for widely disseminated disease. Targeted radiopharmaceutical therapy (TRT) selectively delivers radiation to both the primary tumor and the metastatic sites, and has shown promising results, leading to regulatory approval of certain agents.

JOURNAL OF NUCLEAR MEDICINE (2022)

Article Oncology

Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination

Peter M. Carlson, Ravi B. Patel, Jen Birstler, Matthew Rodriquez, Claire Sun, Amy K. Erbe, Amber M. Bates, Ian Marsh, Joseph Grudzinski, Reinier Hernandez, Alexander A. Pieper, Arika S. Feils, Alexander L. Rakhmilevich, Jamey P. Weichert, Bryan P. Bednarz, Paul M. Sondel, Zachary S. Morris

Summary: The combination of external beam radiation therapy (EBRT) and intratumoral immunocytokine (IC) generates an effective in situ vaccine (ISV) against GD2-positive murine tumors. However, ISV does not produce an adequate response against distant tumors. Additional radiation therapy (RT) to all sites of disease may augment the antitumor responses to ISV.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Article Clinical Neurology

Does a Cancer Diagnosis in Mid-to-Later Life Modify Racial Disparities in Memory Aging?

Marisa R. Eastman, Monica Ospina-Romero, Ashly C. Westrick, Jasdeep S. Kler, Medellena Maria Glymour, Ekland Abdiwahab, Lindsay C. Kobayashi

Summary: This study investigated whether an incident cancer diagnosis affects acute and long-term memory aging differently in older White and Black Americans. The results showed that Black participants experienced faster memory decline than White participants. In Whites, an incident cancer diagnosis was associated with acute memory decline, but not in Blacks. However, White cancer survivors had slower memory decline compared to cancer-free White adults, while this memory advantage was not observed among Black cancer survivors.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2022)

Article Biology

90Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin's Lymphoma

Reinier Hernandez, Kirsti L. Walker, Joseph J. Grudzinski, Eduardo Aluicio-Sarduy, Ravi Patel, Christopher D. Zahm, Anatoly N. Pinchuk, Christopher F. Massey, Ariana N. Bitton, Ryan J. Brown, Paul M. Sondel, Zachary S. Morris, Jonathan W. Engle, Christian M. Capitini, Jamey P. Weichert

COMMUNICATIONS BIOLOGY (2019)

Article Oncology

Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group

Derek A. Mumaw, Allison J. Hazy, Aleksander Vayntraub, Thomas J. Quinn, Kamran Salari, John H. Chang, Noah Kalman, Sanford Katz, James Urbanic, Robert H. Press, Arpi Thukral, Henry Tsai, George E. Laramore, Jason Molitoris, Carlos Vargas, Samir H. Patel, Craig Stevens, Rohan L. Deraniyagala

Summary: This study evaluated contralateral recurrences in patients with oropharyngeal squamous cell carcinoma who received unilateral proton beam therapy. The results showed a favorable contralateral neck failure rate that was comparable to photon irradiation.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Outcomes following hypofractionated radiation therapy alone for surgically unfit early esophageal squamous cell carcinoma patients; a retrospective single center analysis

Kangpyo Kim, Dongryul Oh, Jae Myoung Noh, Yang Won Min, Hong Kwan Kim, Yong Chan Ahn

Summary: This study suggests that hypofractionated radiation therapy alone is a feasible option for early stage esophageal squamous cell carcinoma patients. Particularly, in patients with tumor length < 3 cm, this treatment scheme shows favorable local control rates with low incidence of esophageal toxicities.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy

Lin Chen, Jing Li, Kunpeng Li, Jiang Hu, Qingjie Li, Chenglong Huang, Gaoyuan Wang, Na Liu, Linglong Tang

Summary: This study analyzed the probability of hearing impairment after radiotherapy for nasopharyngeal carcinoma and developed a predictive model, providing dose limitation suggestions to improve patients' quality of life.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

FLASH radiotherapy using high-energy X-rays: Current status of PARTER platform in FLASH research

Yiwei Yang, Jianxin Wang, Feng Gao, Zhen Liu, Tangzhi Dai, Haowen Zhang, Hongyu Zhu, Tingting Wang, Dexin Xiao, Kui Zhou, Zheng Zhou, Dai Wu, Xiaobo Du, Sen Bai

Summary: This paper provides a comprehensive description of the current status of PARTER, which is the first experimental FLASH platform utilizing megavoltage X-rays. It showcases the reliable performance and stability of the dosimeters and monitors used in PARTER, as well as the satisfactory dose distribution and characteristics of the FLASH X-rays. The platform effectively meets the requirements of preclinical research on megavoltage X-ray FLASH and undergoes continuous upgrades.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation

Maria Thor, Kelly Fitzgerald, Aditya Apte, Jung Hun Oh, Aditi Iyer, Otasowie Odiase, Saad Nadeem, Ellen D. Yorke, Jamie Chaft, Abraham J. Wu, Michael Offin, Charles B. Simone Ii, Isabel Preeshagul, Daphna Y. Gelblum, Daniel Gomez, Joseph O. Deasy, Andreas Rimner

Summary: The purpose of this study was to identify predictors of disease progression in early-stage non-small cell lung cancer (NSCLC) patients after receiving definitive stereotactic body radiation therapy (SBRT). The results showed that tumor diameter and SUVmax were the most frequently reported features associated with progression/survival, and a re-fitted model including these two features had the best performance.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

A comprehensive predictive model for radiation-induced brain injury in risk stratification and personalized radiotherapy of nasopharyngeal carcinoma

Yong-Qiao He, Tong-Min Wang, Da-Wei Yang, Wen-Qiong Xue, Chang-Mi Deng, Dan-Hua Li, Wen-Li Zhang, Ying Liao, Ruo-Wen Xiao, Lu-Ting Luo, Hua Diao, Xia-Ting Tong, Yan-Xia Wu, Xue-Yin Chen, Jiang-Bo Zhang, Ting Zhou, Xi-Zhao Li, Pei-Fen Zhang, Xiao-Hui Zheng, Shao-Dan Zhang, Ye-Zhu Hu, Guan-Qun Zhou, Jun Ma, Ying Sun, Wei-Hua Jia

Summary: In this study, researchers aimed to establish a predictive model for radiation-induced brain injury (RBI) in nasopharyngeal carcinoma (NPC) patients by incorporating clinical factors and newly developed genetic variants. They conducted a large-scale retrospective study and a genome-wide association study to develop a polygenic risk score (PRS) for RBI risk prediction. The results showed that the PRS, combined with clinical factors, improved the accuracy of RBI risk stratification and suggested personalized radiotherapy.

RADIOTHERAPY AND ONCOLOGY (2024)

Review Oncology

Brachytherapy is an effective and safe salvage option for re-irradiation in recurrent glioblastoma (rGBM): A systematic review

Xiaoyong Xiang, Zhe Ji, Jing Jin

Summary: A review of studies suggests that brachytherapy as a salvage therapy for recurrent glioblastoma shows acceptable safety and good post-treatment clinical efficacy for selected patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts

M. Berbee, C. T. Muijs, F. E. M. Voncken, L. Wee, M. Sosef, B. van Etten, J. W. van Sandick, F. A. R. M. Warmerdam, J. J. de Haan, E. Oldehinkel, J. M. van Dieren, L. Boersma, J. A. Langendijk, A. van der Schaaf, J. B. Reitsma, E. Schuit

Summary: This study externally validated a model for predicting 2-year total mortality in lung cancer patients in esophageal cancer patients. The intercept and/or slope of the original model needed adjustment to achieve good performance in esophageal cancer patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Nine years of plan of the day for cervical cancer: Plan library remains effective compared to fully online-adaptive techniques

Dominique Reijtenbagh, Jeremy Godart, Joan Penninkhof, Sandra Quint, Andras Zolnay, Jan-Willem Mens, Mischa Hoogeman

Summary: This study compared the performance of the current PotD strategy with non-adaptive and fully online-adaptive techniques in the treatment of cervical cancer patients. The findings show that the PotD protocol is effective in improving normal tissue sparing compared to no adaptation, while fully online-adaptive approaches can further reduce target volume but come with a more complex workflow.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Prediction of radiation pneumonitis using the effective α/β of lungs and heart in NSCLC patients treated with proton beam therapy

Albrecht Weiss, Steffen Loeck, Ting Xu, Zhongxing Liao, Aswin L. Hoffmann, Esther G. C. Troost

Summary: Traditional models for predicting radiation pneumonitis may not be applicable to non-small cell lung cancer patients treated with passively-scattered proton therapy. The use of effective alpha/beta parameter can predict the occurrence of radiation pneumonitis in these patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Primer shot fractionation with an early treatment break is theoretically superior to consecutive weekday fractionation schemes for early-stage non-small cell lung cancer

Z. A. R. Gouw, J. Jeong, A. Rimner, N. Y. Lee, A. Jackson, A. Fu, J-j. Sonke, J. O. Deasy

Summary: This study investigates the effectiveness of non-uniform fractionation schedules in radiotherapy for early-stage non-small cell lung cancer. Through modeling, optimized schedules are proposed to minimize local failures and toxicity risk. The results suggest that non-standard primer shot fractionation can reduce hypoxia-induced radioresistance and improve treatment outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity

Sara Ronchi, Alessandro Cicchetti, Maria Bonora, Rossana Ingargiola, Anna Maria Camarda, Stefania Russo, Sara Imparato, Paolo Castelnuovo, Ernesto Pasquini, Piero Nicolai, Mohssen Ansarin, Michele Del Vecchio, Marco Benazzo, Ester Orlandi, Barbara Vischioni

Summary: This study evaluates the efficacy and toxicity of carbon ion radiotherapy (CIRT) in locally advanced head and neck mucosal melanoma patients. The results show that CIRT is safe and effective in treating the local region, and immunotherapy after relapse can improve overall survival. However, further prospective trials are needed to assess the role of targeted/immune- systemic therapy in this disease.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

The rise of negative portrayals of radiation oncology: A textual analysis of media news

Dominik Wawrzuta, Justyna Klejdysz, Marzanna Chojnacka

Summary: This study analyzed articles about radiation oncology published in The New York Times since its inception in 1851, and identified changes in media sentiment and prevalent themes related to radiotherapy. The findings suggest an increasing negative sentiment in media coverage towards radiotherapy, with a shift towards reporting treatment errors, toxicity, and ineffectiveness.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses

Elaine Limkin, Pierre Blanchard, Benjamin Lacas, Jean Bourhis, Mahesh Parmar, Lisa Licitra, Quynh-Thu Le, Sue S. Yom, Catherine Fortpied, Johannes Langendijk, Jan B. Vermorken, Jacques Bernier, Jens Overgaard, Jonathan Harris, Jean-Pierre Pignon, Anne Auperin

Summary: This study investigated the impact of season of radiotherapy on the outcomes of head and neck squamous cell cancer patients. The results showed that the season of radiotherapy did not have any significant effect on patient outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS)

Fabio L. Cury, Gustavo A. Viani, Andre G. Gouveia, Camila V. S. Freire, Gabriel de A. Grisi, Fabio Y. Moraes

Summary: In limb-sparing treatment of soft tissue sarcoma patients, a 5-day course of preoperative radiotherapy results in high local control and favorable R0 margins, with acceptable complication rates, particularly for patients receiving higher biological equivalent doses.

RADIOTHERAPY AND ONCOLOGY (2024)